Porton Pharma Solutions Ltd
SZSE:300363
Income Statement
Earnings Waterfall
Porton Pharma Solutions Ltd
Revenue
|
4.9B
CNY
|
Cost of Revenue
|
-2.6B
CNY
|
Gross Profit
|
2.2B
CNY
|
Operating Expenses
|
-1.3B
CNY
|
Operating Income
|
929.3m
CNY
|
Other Expenses
|
-49.8m
CNY
|
Net Income
|
879.5m
CNY
|
Income Statement
Porton Pharma Solutions Ltd
Dec-2013 | Mar-2014 | Jun-2014 | Sep-2014 | Dec-2014 | Mar-2015 | Jun-2015 | Sep-2015 | Dec-2015 | Mar-2016 | Jun-2016 | Sep-2016 | Dec-2016 | Mar-2017 | Jun-2017 | Sep-2017 | Dec-2017 | Mar-2018 | Jun-2018 | Sep-2018 | Dec-2018 | Mar-2019 | Jun-2019 | Sep-2019 | Dec-2019 | Mar-2020 | Jun-2020 | Sep-2020 | Dec-2020 | Mar-2021 | Jun-2021 | Sep-2021 | Dec-2021 | Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | ||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Revenue | |||||||||||||||||||||||||||||||||||||||||
Revenue |
734
N/A
|
723
-2%
|
740
+2%
|
719
-3%
|
987
+37%
|
1 072
+9%
|
1 156
+8%
|
1 155
0%
|
1 021
-12%
|
1 029
+1%
|
1 097
+7%
|
1 194
+9%
|
1 327
+11%
|
1 399
+5%
|
1 307
-7%
|
1 242
-5%
|
1 184
-5%
|
1 039
-12%
|
1 101
+6%
|
1 191
+8%
|
1 185
-1%
|
1 225
+3%
|
1 299
+6%
|
1 430
+10%
|
1 551
+9%
|
1 689
+9%
|
1 852
+10%
|
1 958
+6%
|
2 072
+6%
|
2 224
+7%
|
2 402
+8%
|
2 614
+9%
|
3 105
+19%
|
4 005
+29%
|
5 763
+44%
|
6 293
+9%
|
7 035
+12%
|
6 970
-1%
|
5 460
-22%
|
4 854
-11%
|
|
Gross Profit | |||||||||||||||||||||||||||||||||||||||||
Cost of Revenue |
(451)
|
(449)
|
(455)
|
(444)
|
(634)
|
(707)
|
(783)
|
(781)
|
(692)
|
(670)
|
(679)
|
(760)
|
(825)
|
(862)
|
(820)
|
(750)
|
(754)
|
(690)
|
(734)
|
(820)
|
(793)
|
(837)
|
(866)
|
(926)
|
(995)
|
(1 048)
|
(1 151)
|
(1 169)
|
(1 234)
|
(1 297)
|
(1 364)
|
(1 489)
|
(1 841)
|
(2 251)
|
(2 989)
|
(3 174)
|
(3 398)
|
(3 399)
|
(2 832)
|
(2 630)
|
|
Gross Profit |
283
N/A
|
274
-3%
|
285
+4%
|
275
-3%
|
353
+28%
|
365
+3%
|
373
+2%
|
374
+0%
|
329
-12%
|
358
+9%
|
418
+17%
|
434
+4%
|
502
+16%
|
537
+7%
|
487
-9%
|
492
+1%
|
430
-13%
|
350
-19%
|
367
+5%
|
371
+1%
|
392
+6%
|
388
-1%
|
434
+12%
|
503
+16%
|
556
+10%
|
641
+15%
|
701
+9%
|
789
+13%
|
838
+6%
|
928
+11%
|
1 039
+12%
|
1 125
+8%
|
1 264
+12%
|
1 754
+39%
|
2 774
+58%
|
3 119
+12%
|
3 636
+17%
|
3 571
-2%
|
2 627
-26%
|
2 224
-15%
|
|
Operating Income | |||||||||||||||||||||||||||||||||||||||||
Operating Expenses |
(149)
|
(162)
|
(174)
|
(183)
|
(200)
|
(202)
|
(199)
|
(194)
|
(182)
|
(186)
|
(211)
|
(218)
|
(271)
|
(285)
|
(289)
|
(311)
|
(244)
|
(237)
|
(266)
|
(247)
|
(270)
|
(255)
|
(265)
|
(281)
|
(363)
|
(427)
|
(454)
|
(482)
|
(459)
|
(519)
|
(570)
|
(643)
|
(692)
|
(826)
|
(1 077)
|
(1 194)
|
(1 409)
|
(1 436)
|
(1 355)
|
(1 294)
|
|
Selling, General & Administrative |
(149)
|
(151)
|
(161)
|
(168)
|
(186)
|
(191)
|
(190)
|
(190)
|
(167)
|
(177)
|
(202)
|
(212)
|
(254)
|
(258)
|
(226)
|
(221)
|
(233)
|
(169)
|
(188)
|
(190)
|
(189)
|
(161)
|
(161)
|
(176)
|
(244)
|
(272)
|
(298)
|
(307)
|
(300)
|
(316)
|
(339)
|
(367)
|
(427)
|
(512)
|
(667)
|
(710)
|
(852)
|
(872)
|
(807)
|
(793)
|
|
Research & Development |
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(19)
|
0
|
0
|
0
|
(46)
|
(67)
|
(60)
|
(98)
|
(102)
|
(109)
|
(131)
|
(125)
|
(147)
|
(141)
|
(190)
|
(227)
|
(267)
|
(233)
|
(303)
|
(410)
|
(491)
|
(482)
|
(581)
|
(550)
|
(494)
|
|
Depreciation & Amortization |
0
|
0
|
0
|
0
|
(11)
|
0
|
0
|
0
|
(13)
|
0
|
0
|
0
|
(15)
|
0
|
0
|
0
|
(28)
|
0
|
0
|
0
|
(24)
|
0
|
0
|
0
|
(25)
|
0
|
0
|
0
|
(30)
|
0
|
0
|
0
|
(47)
|
0
|
0
|
0
|
(89)
|
0
|
0
|
0
|
|
Other Operating Expenses |
0
|
(11)
|
(13)
|
(16)
|
(3)
|
(12)
|
(9)
|
(4)
|
(3)
|
(9)
|
(9)
|
(6)
|
(2)
|
(26)
|
(63)
|
(71)
|
17
|
(68)
|
(77)
|
(11)
|
10
|
(34)
|
(6)
|
(3)
|
15
|
(24)
|
(31)
|
(29)
|
12
|
(13)
|
(5)
|
(9)
|
16
|
(11)
|
0
|
7
|
14
|
16
|
2
|
(7)
|
|
Operating Income |
135
N/A
|
112
-17%
|
111
-1%
|
92
-17%
|
153
+67%
|
163
+6%
|
174
+7%
|
180
+3%
|
147
-18%
|
172
+17%
|
207
+20%
|
216
+4%
|
231
+7%
|
252
+9%
|
198
-21%
|
182
-8%
|
186
+2%
|
112
-40%
|
101
-10%
|
125
+23%
|
122
-2%
|
133
+9%
|
169
+27%
|
222
+32%
|
193
-13%
|
214
+11%
|
246
+15%
|
307
+24%
|
379
+24%
|
409
+8%
|
469
+15%
|
482
+3%
|
572
+19%
|
928
+62%
|
1 697
+83%
|
1 925
+13%
|
2 228
+16%
|
2 135
-4%
|
1 272
-40%
|
929
-27%
|
|
Pre-Tax Income | |||||||||||||||||||||||||||||||||||||||||
Interest Income Expense |
(13)
|
(12)
|
(12)
|
(13)
|
(11)
|
(16)
|
(17)
|
(17)
|
(18)
|
(27)
|
(25)
|
(32)
|
(23)
|
(33)
|
(49)
|
(54)
|
(64)
|
(63)
|
(52)
|
(4)
|
(26)
|
20
|
32
|
1
|
1
|
15
|
8
|
(5)
|
(28)
|
(20)
|
(17)
|
(6)
|
(3)
|
(34)
|
20
|
4
|
37
|
27
|
38
|
32
|
|
Non-Reccuring Items |
(6)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
(13)
|
(12)
|
0
|
0
|
(7)
|
22
|
22
|
0
|
36
|
0
|
1
|
1
|
(5)
|
0
|
(1)
|
0
|
(6)
|
(0)
|
(0)
|
(0)
|
(20)
|
0
|
0
|
(3)
|
(19)
|
0
|
0
|
0
|
|
Gain/Loss on Disposition of Assets |
0
|
0
|
0
|
0
|
(5)
|
0
|
0
|
0
|
(7)
|
(2)
|
(4)
|
(4)
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
Total Other Income |
5
|
7
|
6
|
2
|
10
|
5
|
5
|
7
|
10
|
2
|
2
|
2
|
10
|
12
|
13
|
10
|
0
|
0
|
0
|
(0)
|
0
|
(21)
|
(23)
|
(20)
|
4
|
(3)
|
13
|
7
|
19
|
10
|
(5)
|
(8)
|
(0)
|
(18)
|
(22)
|
(20)
|
(1)
|
(16)
|
(18)
|
(18)
|
|
Pre-Tax Income |
121
N/A
|
105
-13%
|
104
-1%
|
81
-23%
|
148
+83%
|
152
+3%
|
162
+7%
|
170
+4%
|
132
-22%
|
146
+11%
|
179
+23%
|
182
+1%
|
205
+13%
|
219
+6%
|
163
-26%
|
138
-15%
|
115
-17%
|
71
-38%
|
71
+1%
|
120
+68%
|
133
+11%
|
132
-1%
|
180
+36%
|
203
+13%
|
193
-5%
|
227
+17%
|
267
+17%
|
308
+15%
|
364
+18%
|
399
+10%
|
447
+12%
|
467
+5%
|
549
+18%
|
876
+60%
|
1 695
+93%
|
1 906
+12%
|
2 246
+18%
|
2 146
-4%
|
1 292
-40%
|
944
-27%
|
|
Net Income | |||||||||||||||||||||||||||||||||||||||||
Tax Provision |
(20)
|
(15)
|
(17)
|
(11)
|
(25)
|
(28)
|
(28)
|
(32)
|
(26)
|
(26)
|
(36)
|
(40)
|
(43)
|
(46)
|
(35)
|
(30)
|
(20)
|
(13)
|
(8)
|
(2)
|
(21)
|
(22)
|
(27)
|
(42)
|
(14)
|
(17)
|
(22)
|
(26)
|
(41)
|
(35)
|
(40)
|
(36)
|
(73)
|
(130)
|
(260)
|
(268)
|
(309)
|
(288)
|
(171)
|
(152)
|
|
Income from Continuing Operations |
101
|
91
|
87
|
69
|
123
|
124
|
134
|
137
|
106
|
120
|
143
|
142
|
162
|
172
|
127
|
108
|
95
|
58
|
63
|
119
|
111
|
110
|
153
|
162
|
180
|
210
|
245
|
282
|
323
|
364
|
406
|
431
|
476
|
746
|
1 435
|
1 638
|
1 936
|
1 858
|
1 121
|
791
|
|
Income to Minority Interest |
(1)
|
(1)
|
1
|
1
|
3
|
4
|
5
|
5
|
5
|
5
|
5
|
6
|
9
|
10
|
11
|
13
|
13
|
15
|
15
|
16
|
13
|
9
|
6
|
1
|
6
|
7
|
7
|
7
|
1
|
1
|
2
|
15
|
48
|
72
|
86
|
103
|
69
|
70
|
82
|
88
|
|
Net Income (Common) |
100
N/A
|
90
-10%
|
88
-3%
|
71
-19%
|
126
+78%
|
127
+1%
|
138
+9%
|
142
+3%
|
110
-22%
|
125
+13%
|
148
+19%
|
148
+0%
|
171
+16%
|
182
+6%
|
138
-24%
|
121
-12%
|
107
-11%
|
73
-32%
|
79
+8%
|
134
+71%
|
125
-7%
|
119
-4%
|
159
+34%
|
163
+2%
|
186
+14%
|
217
+17%
|
251
+16%
|
289
+15%
|
324
+12%
|
364
+12%
|
408
+12%
|
446
+9%
|
524
+17%
|
818
+56%
|
1 522
+86%
|
1 741
+14%
|
2 005
+15%
|
1 928
-4%
|
1 203
-38%
|
880
-27%
|
|
EPS (Diluted) |
0.28
N/A
|
0.23
-18%
|
0.22
-4%
|
0.17
-23%
|
0.31
+82%
|
0.31
N/A
|
0.34
+10%
|
0.35
+3%
|
0.27
-23%
|
0.31
+15%
|
0.36
+16%
|
0.36
N/A
|
0.41
+14%
|
0.43
+5%
|
0.33
-23%
|
0.29
-12%
|
0.25
-14%
|
0.18
-28%
|
0.14
-22%
|
0.29
+107%
|
0.26
-10%
|
0.23
-12%
|
0.31
+35%
|
0.3
-3%
|
0.35
+17%
|
0.41
+17%
|
0.48
+17%
|
0.55
+15%
|
0.6
+9%
|
0.68
+13%
|
0.76
+12%
|
0.83
+9%
|
0.97
+17%
|
1.51
+56%
|
2.78
+84%
|
3.17
+14%
|
3.69
+16%
|
3.58
-3%
|
2.23
-38%
|
1.58
-29%
|